64.92
price up icon0.66%   0.15
 
loading
前日終値:
$64.77
開ける:
$64.77
24時間の取引高:
348.74K
Relative Volume:
0.47
時価総額:
$3.65B
収益:
$76.81M
当期純損益:
$-162.42M
株価収益率:
-21.71
EPS:
-2.99
ネットキャッシュフロー:
$-122.49M
1週間 パフォーマンス:
+3.48%
1か月 パフォーマンス:
+5.24%
6か月 パフォーマンス:
-17.56%
1年 パフォーマンス:
+20.46%
1日の値動き範囲:
Value
$63.77
$66.21
1週間の範囲:
Value
$61.51
$66.21
52週間の値動き範囲:
Value
$47.86
$107.37

Arcellx Inc Stock (ACLX) Company Profile

Name
名前
Arcellx Inc
Name
セクター
Healthcare (1171)
Name
電話
240-327-0603
Name
住所
800 BRIDGE PARKWAY, REDWOOD CITY
Name
職員
163
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
ACLX's Discussions on Twitter

ACLX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ACLX
Arcellx Inc
65.05 3.65B 76.81M -162.42M -122.49M -2.99
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
444.61 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
518.52 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
320.22 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.38 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
240.03 28.51B 3.81B -644.79M -669.77M -6.24

Arcellx Inc Stock (ACLX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2024-10-08 開始されました Redburn Atlantic Buy
2024-09-03 開始されました Cantor Fitzgerald Overweight
2024-05-31 開始されました Piper Sandler Overweight
2024-03-07 開始されました Morgan Stanley Overweight
2024-01-04 繰り返されました Needham Buy
2023-12-19 開始されました Scotiabank Sector Outperform
2023-10-30 開始されました TD Cowen Outperform
2023-10-17 開始されました UBS Buy
2023-05-18 開始されました Truist Buy
2023-04-14 開始されました Robert W. Baird Outperform
2023-03-14 開始されました Stifel Buy
2023-02-13 開始されました H.C. Wainwright Buy
2022-12-13 再開されました BofA Securities Buy
2022-10-31 開始されました Guggenheim Buy
2022-10-27 開始されました Needham Buy
2022-07-20 開始されました Canaccord Genuity Buy
2022-03-01 開始されました BofA Securities Buy
2022-03-01 開始されました SVB Leerink Outperform
すべてを表示

Arcellx Inc (ACLX) 最新ニュース

pulisher
Jun 17, 2025

Citi initiates Arcellx stock with buy rating on cell therapy potential - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Citi initiates Arcellx stock with buy rating on cell therapy potential By Investing.com - Investing.com South Africa

Jun 17, 2025
pulisher
Jun 17, 2025

Cancer Cell Market Exclusive Report with Detailed Study Analysis | Abbott Laboratories, Cellectis, Arcellx, GE - newstrail.com

Jun 17, 2025
pulisher
Jun 17, 2025

Citigroup Initiates Arcellx at Buy With $110 Price Target - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Arcellx initiated with a Buy at Citi - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Arcellx (ACLX): Citi Initiates Buy Rating with Promising Outlook | ACLX Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 16, 2025

Aileen Fernandes | People on The MoveSan Francisco Business Times - The Business Journals

Jun 16, 2025
pulisher
Jun 16, 2025

Aileen Fernandes - The Business Journals

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx Inc’s Anito-cel: A Promising Market Entrant with Superior Efficacy and Safety in Multiple Myeloma Treatment - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx Inc’s Anito Cel Therapy: A Promising Contender in Multiple Myeloma Treatment with Strong Market Potential - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

ACLX: HC Wainwright & Co. Reiterates Buy Rating with $115 Target | ACLX Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx stock maintains buy rating at H.C. Wainwright on launch plans - Investing.com

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx Inc’s Strategic Partnership with Kite Enhances Anito-cel Therapy Launch and Market Position - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Promising Potential of Arcellx Inc’s Anito-cel Therapy Drives Buy Rating - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Positive Outlook for Arcellx Inc: Promising Anito-cel Therapy and Strategic Market Positioning - TipRanks

Jun 16, 2025
pulisher
Jun 16, 2025

Arcellx Inc’s Promising Market Position and Growth Potential in Multiple Myeloma Therapy - TipRanks

Jun 16, 2025
pulisher
Jun 14, 2025

Rhumbline Advisers Raises Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Transcript : Arcellx, Inc.Special Call - MarketScreener

Jun 13, 2025
pulisher
Jun 12, 2025

(ACLX) Technical Data - news.stocktradersdaily.com

Jun 12, 2025
pulisher
Jun 12, 2025

Arcellx’s SWOT analysis: CAR-T pioneer’s stock poised for myeloma market shake-up - Investing.com

Jun 12, 2025
pulisher
Jun 11, 2025

arcellx director Kavita Patel sells shares worth $101,040 By Investing.com - Investing.com Nigeria

Jun 11, 2025
pulisher
Jun 11, 2025

arcellx director Kavita Patel sells shares worth $101,040 - Investing.com

Jun 11, 2025
pulisher
Jun 11, 2025

Brokers Set Expectations for Arcellx FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

Arcellx, Inc. (NASDAQ:ACLX) Shares Sold by Two Sigma Investments LP - Defense World

Jun 09, 2025
pulisher
Jun 07, 2025

FY2026 EPS Estimates for Arcellx Lifted by Leerink Partnrs - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Squarepoint Ops LLC Sells 4,670 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jun 06, 2025
pulisher
Jun 06, 2025

Arcellx FY2029 EPS Forecast Raised by Leerink Partnrs - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Kalkine: Top NASDAQ Stocks Arcellx’s Role by Kalkine - Kalkine Media

Jun 05, 2025
pulisher
Jun 05, 2025

Two Sigma Advisers LP Acquires 1,100 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jun 05, 2025
pulisher
Jun 03, 2025

Millennium Management LLC Raises Stock Holdings in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Ameriprise Financial Inc. Sells 945 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

Jun 03, 2025
pulisher
Jun 03, 2025

Arcellx, Inc. (NASDAQ:ACLX) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Jun 03, 2025
pulisher
May 31, 2025

How to Take Advantage of moves in (ACLX) - news.stocktradersdaily.com

May 31, 2025
pulisher
May 29, 2025

Nuveen Asset Management LLC Sells 9,110 Shares of Arcellx, Inc. (NASDAQ:ACLX) - Defense World

May 29, 2025
pulisher
May 28, 2025

Arcellx Inc Holds Annual Stockholders Meeting - TipRanks

May 28, 2025
pulisher
May 23, 2025

New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs - Benzinga

May 23, 2025
pulisher
May 22, 2025

Thinking Of Buying Arcellx Inc (NASDAQ: ACLX) Stock? Here’s What You Need To Know - Stocksregister

May 22, 2025
pulisher
May 21, 2025

Annual Oncology Innovation Summit and Its Investor Event During EHA2025 - Business Wire

May 21, 2025
pulisher
May 21, 2025

Arcellx Announces Its Participation at TD Cowen’s 6th Annual Oncology Innovation Summit and Its Investor Event During EHA2025 - Bluefield Daily Telegraph

May 21, 2025
pulisher
May 21, 2025

Dycom Industries Posts Upbeat Earnings, Joins WeRide, Keysight Technologies And Other Big Stocks Moving Higher On Wednesday - Benzinga

May 21, 2025
pulisher
May 20, 2025

Baron Discovery Fund Initiated a Position in Arcellx (ACLX) - Insider Monkey

May 20, 2025
pulisher
May 19, 2025

BNP Paribas Financial Markets Makes New $1.53 Million Investment in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

May 19, 2025
pulisher
May 16, 2025

Arcellx Inc (ACLX) Receives a Buy from Canaccord Genuity - The Globe and Mail

May 16, 2025
pulisher
May 16, 2025

Mercer Global Advisors Inc. ADV Takes $278,000 Position in Arcellx, Inc. (NASDAQ:ACLX) - Defense World

May 16, 2025
pulisher
May 16, 2025

Arcellx, Inc. Reports Q1 2025 Financial Results - TipRanks

May 16, 2025
pulisher
May 15, 2025

Arcellx Inc’s Anito-cel Shows Promising Results in Phase 2 Trial, Earning Buy Rating from Analyst - TipRanks

May 15, 2025
pulisher
May 15, 2025

Cantor Fitzgerald Expects Reduced Earnings for Arcellx - Defense World

May 15, 2025
pulisher
May 14, 2025

Insiders At Arcellx Sold US$2.6m In Stock, Alluding To Potential Weakness - simplywall.st

May 14, 2025
pulisher
May 14, 2025

Promising Clinical Data and Strong Safety Profile Lead to Buy Rating for Arcellx Inc’s Anito-cel - TipRanks

May 14, 2025
pulisher
May 14, 2025

Arcellx Inc’s Anito-cel Shows Promising Efficacy and Safety in Multiple Myeloma, Earning Buy Rating - TipRanks

May 14, 2025
pulisher
May 14, 2025

Arcellx's Potential Multiple Myeloma Treatment Shows 97% Overall Response Rate in Phase 2 Study; Shares Rise - marketscreener.com

May 14, 2025

Arcellx Inc (ACLX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Arcellx Inc (ACLX) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Patel Kavita
Director
Jun 10 '25
Sale
67.36
1,500
101,040
0
$20.42
price down icon 1.37%
$35.45
price up icon 0.65%
$21.06
price down icon 1.92%
$101.83
price down icon 0.41%
$105.86
price down icon 0.39%
biotechnology ONC
$244.00
price down icon 3.69%
大文字化:     |  ボリューム (24 時間):